MD

Mikael Dolsten

Former Board Member

Calithera Biosciences

Roles

Former Board MemberatCalithera Biosciences
Chairperson of the Board of DirectorsatOrbis Medicines
Chief Scientific Officer & President, Worldwide R&D and MedicalatPfizer
Board MemberatCertara

Therapeutic Areas

Calithera Biosciences Pipeline

DrugIndicationPhase
CB-1158 (INCB001158)Advanced/Metastatic Solid TumorsPhase 1/2
CB-839 (Telaglenastat)Renal Cell CarcinomaPhase 2
CB-280Cystic FibrosisPreclinical/Phase 1